Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma

NCT01870609 is registered in ClinicalTrials.gov with Verastem, Inc. as lead sponsor.

NCT NCT01870609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01870609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma
Lead sponsor
Verastem, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2013
Completion date
January 31, 2016
Enrollment
344 (actual)
Sites
73

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pleural mesothelioma